| SEGMENT REPORTING |
Effective
January 1, 2026, the Chief Executive Officer (“CEO”) and Executive Chairman serve as the Chief Operating Decision Maker
(“CODM”), organizing the Company, managing resource allocations and measuring performance among two
operating and reportable segments: (i) Healthcare IT and (ii) Medical Practice Management. From January 1, 2025, through December
31, 2025, the Executive Chairman and the two Co-CEOs served as the CODM. We report our segment information based on the internal
reporting used by management for making decisions and assessing performance of our reportable segments.
The
CODM evaluates the financial performance of the business units on the basis of revenue, certain individual and total operating
expenses and operating income (loss) excluding unallocated amounts, which are mainly corporate overhead costs, for assessing
operating results and the allocation of resources. Our CODM does not evaluate operating segments using asset or liability
information. The CODM uses segment revenue, certain segment operating expenses and segment operating income (loss) to manage the
segments, comparing actual results to forecasted amounts and investigating the reasons for significant variances. Our CODM does not
evaluate operating segments using asset or liability information. Currently, a focus is being placed on reducing costs and managing
global headcount. The segment revenue and segment operating income (loss) is also used to assess the performance of personnel and in
establishing their compensation.
The
Healthcare IT segment includes revenue cycle management, SaaS solutions and other services. The Medical Practice Management segment includes
the management of three medical practices. Each segment is considered a reporting unit. The accounting policies of the segments are
the same as those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC
on March 12, 2026. The following table presents revenues, operating expenses and operating income (loss) by reportable segment:
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
| | |
| | |
| | |
| |
| | |
Six Months Ended June 30, 2026 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| Net revenue | |
$ | 55,698 | | |
$ | 7,452 | (a) | |
$ | 63,150 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 28,259 | | |
| 6,048 | | |
| 34,307 | |
| Selling and marketing | |
| 2,704 | | |
| 10 | | |
| 2,714 | |
| General and administrative | |
| 5,223 | | |
| 1,360 | | |
| 6,583 | |
| Research and development | |
| 4,610 | | |
| - | | |
| 4,610 | |
| Change in contingent consideration | |
| 23 | | |
| - | | |
| 23 | |
| Depreciation and amortization | |
| 7,603 | | |
| 165 | | |
| 7,768 | |
| Restructuring costs | |
| | | |
| | | |
| | |
| Total operating expenses | |
| 48,422 | | |
| 7,583 | | |
| 56,005 | |
| Segment operating income (loss) | |
$ | 7,276 | | |
$ | (131 | ) | |
| 7,145 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss): | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (4,283 | ) |
| Net interest expense | |
| | | |
| | | |
| (790 | ) |
| Other income | |
| | | |
| | | |
| 126 | |
| Income before income taxes | |
| | | |
| | | |
$ | |
| | |
| | |
| | |
| |
| | |
Three Months Ended June 30, 2026 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| | |
| | |
| | |
| |
| Net revenue | |
$ | 28,194 | | |
$ | 3,686 | (a) | |
$ | 31,880 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 14,436 | | |
| 3,021 | | |
| 17,457 | |
| Selling and marketing | |
| 1,298 | | |
| 2 | | |
| 1,300 | |
| General and administrative | |
| 2,550 | | |
| 717 | | |
| 3,267 | |
| Research and development | |
| 2,194 | | |
| - | | |
| 2,194 | |
| Change in contingent consideration | |
| (34 | ) | |
| - | | |
| (34 | ) |
| Depreciation and amortization | |
| 3,648 | | |
| 83 | | |
| 3,731 | |
| Total operating expenses | |
| 24,092 | | |
| 3,823 | | |
| 27,915 | |
| Segment operating income (loss) | |
$ | 4,102 | | |
$ | (137 | ) | |
| 3,965 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss) | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (2,103 | ) |
| Net interest expense | |
| | | |
| | | |
| (742 | ) |
| Other income | |
| | | |
| | | |
| 104 | |
| Income before income taxes | |
| | | |
| | | |
$ | |
| | |
| | |
| | |
| |
| | |
Six Months Ended June 30, 2025 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| Net revenue | |
$ | 48,719 | | |
$ | 6,290 | (a) | |
$ | 55,009 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 24,666 | | |
| 5,278 | | |
| 29,944 | |
| Selling and marketing | |
| 2,234 | | |
| 15 | | |
| 2,249 | |
| General and administrative | |
| 4,455 | | |
| 1,211 | | |
| 5,666 | |
| Research and development | |
| 2,255 | | |
| - | | |
| 2,255 | |
| Depreciation and amortization | |
| 6,555 | | |
| 164 | | |
| 6,719 | |
| Restructuring costs | |
| 137 | | |
| - | | |
| 137 | |
| Total operating expenses | |
| 40,302 | | |
| 6,668 | | |
| 46,970 | |
| Segment operating income (loss) | |
$ | 8,417 | | |
$ | (378 | ) | |
| 8,039 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss): | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (3,024 | ) |
| Net interest expense | |
| | | |
| | | |
| (33 | ) |
| Other expense | |
| | | |
| | | |
| (49 | ) |
| Income before income taxes | |
| | | |
| | | |
$ | |
| | |
| | |
| | |
| |
| | |
Three Months Ended June 30, 2025 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| Net revenue | |
$ | 24,077 | | |
$ | 3,300 | (a) | |
$ | 27,377 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 11,763 | | |
| 2,717 | | |
| 14,480 | |
| Selling and marketing | |
| 1,110 | | |
| 8 | | |
| 1,118 | |
| General and administrative | |
| 2,343 | | |
| 569 | | |
| 2,912 | |
| Research and development | |
| 1,020 | | |
| - | | |
| 1,020 | |
| Depreciation and amortization | |
| 3,300 | | |
| 82 | | |
| 3,382 | |
| Restructuring costs | |
| 23 | | |
| - | | |
| 23 | |
| Total operating expenses | |
| 19,559 | | |
| 3,376 | | |
| 22,935 | |
| Segment operating income (loss) | |
$ | 4,518 | | |
$ | (76 | ) | |
| 4,442 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss) | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (1,446 | ) |
| Net interest expense | |
| | | |
| | | |
| (17 | ) |
| Other expense | |
| | | |
| | | |
| (35 | ) |
| Income before income taxes | |
| | | |
| | | |
$ | |
| (a) | This revenue represents
fees based on our actual costs plus a percentage of the operating profit. |
|